Clinical Trial Update: OPSCC N0 Nodal Control With Reduced IMRT [NA]

View source ↗

Summary

Clinical trial update for OPSCC with reduced IMRT in HPV-associated disease; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-associated Oropharyngeal Cancer
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Paul W. Read, MD | Conditions: Oropharyngeal Squamous Cell Carcinoma (OPSCCA), HPV (Human Papillomavirus)-Associated | NA | Status: TERMINATED | Results posted: 2022-10-12